Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)
Free Medical Books

  Prostate Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 250 articles:
HTML format
Text format



Single Articles


    June 2012
  1. YU JB
    In regard to "Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series." (Int J Radiat Oncol Biol Phys 2012;83:624-629).
    Int J Radiat Oncol Biol Phys. 2012;83:481.
    PubMed     Text format     Related articles   



    May 2012
  2. ZWAHLEN DR , Lang S, Hrbacek J, Glanzmann C, et al
    The Use of Photon Beams of a Flattening Filter-free Linear Accelerator for Hypofractionated Volumetric Modulated Arc Therapy in Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



    April 2012
  3. TIBERI DA , Carrier JF, Beauchemin MC, Nguyen TV, et al
    Impact of Concurrent Androgen Deprivation on Fiducial Marker Migration in External-beam Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. WILBERT J , Baier K, Hermann C, Flentje M, et al
    Accuracy of Real-time Couch Tracking During 3-dimensional Conformal Radiation Therapy, Intensity modulated Radiation Therapy, and Volumetric modulated Arc Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. ARCANGELI S , Strigari L, Gomellini S, Saracino B, et al
    Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. BOUCHAERT P , Guerif S, Debiais C, Irani J, et al
    DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. TAI P , Tonita J, Woitas C, Zhu T, et al
    Treatment Outcomes in Non-Metastatic Prostate Cancer Patients With Ultra-High Prostate-Specific Antigen.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  8. MORROW NV , Lawton CA, Qi XS, Li XA, et al
    Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration.
    Int J Radiat Oncol Biol Phys. 2012;82:e733-8.
    PubMed     Text format     Related articles    Abstract available



  9. LAWTON CA , Yan Y, Lee WR, Gillin M, et al
    Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
    Int J Radiat Oncol Biol Phys. 2012;82:e795-801.
    PubMed     Text format     Related articles    Abstract available



  10. WHALEY JT , Levy LB, Swanson DA, Pugh TJ, et al
    Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2012;82:e765-71.
    PubMed     Text format     Related articles    Abstract available



  11. CHUNG E , Stenmark MH, Evans C, Narayana V, et al
    Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
    Int J Radiat Oncol Biol Phys. 2012;82:1944-8.
    PubMed     Text format     Related articles    Abstract available



  12. MALETZ KL , Ennis RD, Ostenson J, Pevsner A, et al
    Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
    Int J Radiat Oncol Biol Phys. 2012;82:1912-7.
    PubMed     Text format     Related articles    Abstract available



  13. STANIC S , Mathai M, Cui J, Purdy JA, et al
    Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys. 2012;82:1897-902.
    PubMed     Text format     Related articles    Abstract available



  14. NOYES WR , Hosford CC, Schultz SE
    Human collagen injections to reduce rectal dose during radiotherapy.
    Int J Radiat Oncol Biol Phys. 2012;82:1918-22.
    PubMed     Text format     Related articles    Abstract available



  15. GEINITZ H , Riegel MG, Thamm R, Astner ST, et al
    Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
    Int J Radiat Oncol Biol Phys. 2012;82:1930-7.
    PubMed     Text format     Related articles    Abstract available



  16. KHOO EL , Schick K, Plank AW, Poulsen M, et al
    Prostate contouring variation: can it be fixed?
    Int J Radiat Oncol Biol Phys. 2012;82:1923-9.
    PubMed     Text format     Related articles    Abstract available



  17. REN L , Chetty IJ, Zhang J, Jin JY, et al
    Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map.
    Int J Radiat Oncol Biol Phys. 2012;82:1584-93.
    PubMed     Text format     Related articles    Abstract available



  18. JONSSON JH , Garpebring A, Karlsson MG, Nyholm T, et al
    Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
    Int J Radiat Oncol Biol Phys. 2012;82:1612-8.
    PubMed     Text format     Related articles    Abstract available



  19. O'DANIEL J , Das S, Wu QJ, Yin FF, et al
    Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.
    Int J Radiat Oncol Biol Phys. 2012;82:1567-74.
    PubMed     Text format     Related articles    Abstract available



    March 2012
  20. MALONE S , Croke J, Roustan-Delatour N, Belanger E, et al
    Postoperative Radiotherapy for Prostate Cancer: A Comparison of Four Consensus Guidelines and Dosimetric Evaluation of 3D-CRT Versus Tomotherapy IMRT.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  21. VALENTINI AL , Gui B, D'Agostino GR, Mattiucci G, et al
    Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  22. DAL PRA A , Milosevic M, Hill R, Wouters B, et al
    Hypoxia, Androgen Deprivation and Systemic Metastases in Prostate Cancer (In Response to "Antivascular Effects of Neoadjuvant Androgen Deprivation for Prostate Cancer: An In Vivo Human Study Using Susceptibility and Relaxitivity Dynamic MRI": In Regar
    Int J Radiat Oncol Biol Phys. 2012;82:1319.
    PubMed     Text format     Related articles   



  23. REVANNASIDDAIAH S , Gupta MK, Seam RK, Madabhavi I, et al
    Pelvic Nodal Radiotherapy in Patients With Unfavorable Intermediate and High-Risk Prostate Cancer: Evidence, Rationale, and Future Directions: In Regard to Morikawa and Roach III (Int J Radiat Oncol Biol Phys 2011 May 1;80:6-16).
    Int J Radiat Oncol Biol Phys. 2012;82:1318.
    PubMed     Text format     Related articles   



  24. BOWES D , Crook J
    In regard to "dose escalation in the radiation therapy of prostate cancer" (int j radiat oncol biol phys 2011;80:1289-1291).
    Int J Radiat Oncol Biol Phys. 2012;82:1317-8.
    PubMed     Text format     Related articles   



  25. RIAZ N , Afaq A, Akin O, Pei X, et al
    Pretreatment Endorectal Coil Magnetic Resonance Imaging Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated With Combination Brachytherapy and External-Beam Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  26. COURDI A
    On the parameters of the linear-quadratic model: in regard to the editorial by Glatstein.
    Int J Radiat Oncol Biol Phys. 2012;82:1317.
    PubMed     Text format     Related articles   



  27. BRENNER DJ , Sachs RK, Peters LJ, Withers HR, et al
    We forget at our peril the lessons built into the alpha/beta model.
    Int J Radiat Oncol Biol Phys. 2012;82:1312-4.
    PubMed     Text format     Related articles   



  28. DEVILLE C , Vapiwala N, Hwang WT, Lin H, et al
    Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Int J Radiat Oncol Biol Phys. 2012;82:1389-96.
    PubMed     Text format     Related articles    Abstract available



  29. FORTUIN AS , Deserno WM, Meijer HJ, Jager GJ, et al
    Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  30. JANG JW , Hwang WT, Guzzo TJ, Wein AJ, et al
    Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  31. MARTINEZ-MONGE R , Moreno M, Ciervide R, Cambeiro M, et al
    External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcome.
    Int J Radiat Oncol Biol Phys. 2012;82:e469-76.
    PubMed     Text format     Related articles    Abstract available



  32. CHOPRA S , Toi A, Taback N, Evans A, et al
    Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.
    Int J Radiat Oncol Biol Phys. 2012;82:e441-8.
    PubMed     Text format     Related articles    Abstract available



  33. AL-UBAIDI FL , Schultz N, Egevad L, Granfors T, et al
    Castration Therapy of Prostate Cancer Results in Downregulation of HIF-1alpha Levels.
    Int J Radiat Oncol Biol Phys. 2012;82:1243-8.
    PubMed     Text format     Related articles    Abstract available



  34. KING CR
    Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orange.
    Int J Radiat Oncol Biol Phys. 2012;82:1045-6.
    PubMed     Text format     Related articles   



  35. GROENENDAAL G , Borren A, Moman MR, Monninkhof E, et al
    Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.
    Int J Radiat Oncol Biol Phys. 2012;82:e537-44.
    PubMed     Text format     Related articles    Abstract available



  36. MERRICK GS , Wallner KE, Butler WM, Galbreath RW, et al
    20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trial.
    Int J Radiat Oncol Biol Phys. 2012;82:e449-55.
    PubMed     Text format     Related articles    Abstract available



  37. PARK JJ , Chen MH, Loffredo M, D'Amico AV, et al
    Prostate-specific antigen velocity before and after elimination of factors that can confound the prostate-specific antigen level.
    Int J Radiat Oncol Biol Phys. 2012;82:1217-21.
    PubMed     Text format     Related articles    Abstract available



  38. SOTO DE , Passarelli MN, Daignault S, Sandler HM, et al
    Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients.
    Int J Radiat Oncol Biol Phys. 2012;82:1227-32.
    PubMed     Text format     Related articles    Abstract available



    February 2012
  39. SHAH A , Efstathiou JA, Paly JJ, Halpern SD, et al
    Prospective Preference Assessment of Patients' Willingness to Participate in a Randomized Controlled Trial of Intensity-Modulated Radiotherapy Versus Proton Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  40. IPPOLITO E , Massaccesi M, Digesu' C, Deodato F, et al
    Early Proctoscopy Is a Surrogate Endpoint of Late Rectal Toxicity in Prostate Cancer Treated with Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  41. GOGNA NK , Baxi S, Hickey B, Baumann K, et al
    Split-Course, High-Dose Palliative Pelvic Radiotherapy for Locally Progressive Hormone-Refractory Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  42. ARRAYEH E , Westphalen AC, Kurhanewicz J, Roach M 3rd, et al
    Does Local Recurrence of Prostate Cancer After Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI Study.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  43. DINAN MA , Robinson TJ, Zagar TM, Scales CD Jr, et al
    Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999-2007.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  44. ZELEFSKY MJ , Kollmeier M, Cox B, Fidaleo A, et al
    Improved Clinical Outcomes with High-Dose Image Guided Radiotherapy Compared with Non-IGRT for the Treatment of Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  45. ABDOLLAH F , Sun M, Schmitges J, Thuret R, et al
    Competing-risks Mortality After Radiotherapy vs. Observation for Localized Prostate Cancer: A Population-based Study.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  46. SHOWALTER TN , Ohri N, Teti KG, Foley KA, et al
    Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
    Int J Radiat Oncol Biol Phys. 2012;82:e233-8.
    PubMed     Text format     Related articles    Abstract available



  47. SEFROVA J , Odrazka K, Paluska P, Belobradek Z, et al
    Magnetic resonance imaging in postprostatectomy radiotherapy planning.
    Int J Radiat Oncol Biol Phys. 2012;82:911-8.
    PubMed     Text format     Related articles    Abstract available



  48. SHENG K , Jones R, Yang W, Saraiya S, et al
    3D dose verification using tomotherapy CT detector array.
    Int J Radiat Oncol Biol Phys. 2012;82:1013-20.
    PubMed     Text format     Related articles    Abstract available



  49. SENTHI S , Gill SS, Haworth A, Kron T, et al
    Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys. 2012;82:998-1005.
    PubMed     Text format     Related articles    Abstract available



  50. HINNEN KA , Monninkhof EM, Battermann JJ, van Roermund JG, et al
    Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2012;82:883-8.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  51. WATTSON DA , Chen MH, Moul JW, Moran BJ, et al
    The Number of High-Risk Factors and the Risk of Prostate Cancer-Specific Mortality After Brachytherapy: Implications for Treatment Selection.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  52. HOLMES JA , Wang AZ, Hoffman KE, Hendrix LH, et al
    Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  53. ALUWINI S , van Rooij PH, Kirkels WJ, Jansen PP, et al
    High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naive Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  54. SHEN X , Keith SW, Mishra MV, Dicker AP, et al
    The Impact of Brachytherapy on Prostate Cancer-Specific Mortality for Definitive Radiation Therapy of High-Grade Prostate Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  55. CROKE J , Malone S, Roustan Delatour N, Belanger E, et al
    Postoperative Radiotherapy in Prostate Cancer: The Case of the Missing Target.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  56. ALIZADEH M , Sylvestre MP, Zilli T, Van Nguyen T, et al
    Effect of Statins and Anticoagulants on Prostate Cancer Aggressiveness.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  57. EDELMAN S , Liauw SL, Rossi PJ, Cooper S, et al
    High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  58. MYREHAUG S , Chan G, Craig T, Weinberg V, et al
    A Treatment Planning and Acute Toxicity Comparison of Two Pelvic Nodal Volume Delineation Techniques and Delivery Comparison of Intensity-Modulated Radiotherapy Versus Volumetric Modulated Arc Therapy for Hypofractionated High-Risk Prostate Cancer Rad
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



  59. SANDHU GK , Dunscombe P, Meyer T, Pavamani S, et al
    Inter- and intra-observer variability in prostate definition with tissue harmonic and brightness mode imaging.
    Int J Radiat Oncol Biol Phys. 2012;82:e9-16.
    PubMed     Text format     Related articles    Abstract available



  60. KOONTZ BF , Tsivian M, Mouraviev V, Sun L, et al
    Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers.
    Int J Radiat Oncol Biol Phys. 2012;82:200-3.
    PubMed     Text format     Related articles    Abstract available



  61. SMEENK RJ , Hopman WP, Hoffmann AL, van Lin EN, et al
    Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.
    Int J Radiat Oncol Biol Phys. 2012;82:145-52.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  62. VUKY J , Pham HT, Warren S, Douglass E, et al
    Phase II Study of Long-Term Androgen Suppression with Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. PARK SS , Yan D, McGrath S, Dilworth JT, et al
    Adaptive Image-guided Radiotherapy (IGRT) Eliminates the Risk of Biochemical Failure Caused by the Bias of Rectal Distension in Prostate Cancer Treatment Planning: Clinical Evidence.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  64. GHILEZAN M , Martinez A, Gustason G, Krauss D, et al
    High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  65. ZELEFSKY MJ , Housman DM, Pei X, Alicikus Z, et al
    Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  66. PARK SY , Kim CK, Park BK, Park W, et al
    Early Changes in Apparent Diffusion Coefficient from Diffusion-Weighted MR Imaging During Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. LILLEBY W , Tafjord G, Raabe NK
    Implementation of High-dose-rate Brachytherapy and Androgen Deprivation in Patients with Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  68. KAHN S , Jani A, Edelman S, Rossi P, et al
    Matched Cohort Analysis of Outcomes of Definitive Radiotherapy for Prostate Cancer in Human Immunodeficiency Virus-Positive Patients.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. HUANG J , Vicini FA, Williams SG, Ye H, et al
    Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  70. LIPS IM , van Gils CH, Kotte AN, van Leerdam ME, et al
    A Double-Blind Placebo-Controlled Randomized Clinical Trial with Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  71. VESPRINI D , Catton C, Jacks L, Lockwood G, et al
    Inverse Relationship Between Biochemical Outcome and Acute Toxicity After Image-guided Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  72. FORSYTHE K , Blacksburg S, Stone N, Stock RG, et al
    Intensity-Modulated Radiotherapy Causes Fewer Side Effects than Three-Dimensional Conformal Radiotherapy When Used in Combination with Brachytherapy for the Treatment of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  73. ABDOLLAH F , Cozzarini C, Suardi N, Gallina A, et al
    Indications for Pelvic Nodal Treatment in Prostate Cancer should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  74. TUNIO M , Hashmi A
    Response to "risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size" (int j radiat oncol biol phys 2011;79:1318-1322).
    Int J Radiat Oncol Biol Phys. 2011;81:1195-6.
    PubMed     Text format     Related articles   



  75. VICINI FA , Shah C, Kestin L, Ghilezan M, et al
    Identifying differences between biochemical failure and cure: incidence rates and predictors.
    Int J Radiat Oncol Biol Phys. 2011;81:e369-75.
    PubMed     Text format     Related articles    Abstract available



  76. SHIMIZU S , Osaka Y, Shinohara N, Sazawa A, et al
    Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
    Int J Radiat Oncol Biol Phys. 2011;81:e393-9.
    PubMed     Text format     Related articles    Abstract available



  77. ZILLI T , Taussky D, Donath D, Le HP, et al
    Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
    Int J Radiat Oncol Biol Phys. 2011;81:e377-83.
    PubMed     Text format     Related articles    Abstract available



  78. WINKFIELD KM , Chen MH, Dosoretz DE, Salenius SA, et al
    Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
    Int J Radiat Oncol Biol Phys. 2011;81:e345-50.
    PubMed     Text format     Related articles    Abstract available



  79. KACHIKWU EL , Iwamoto KS, Liao YP, DeMarco JJ, et al
    Radiation enhances regulatory T cell representation.
    Int J Radiat Oncol Biol Phys. 2011;81:1128-35.
    PubMed     Text format     Related articles    Abstract available



  80. BOGGULA R , Jahnke L, Wertz H, Lohr F, et al
    Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
    Int J Radiat Oncol Biol Phys. 2011;81:1168-75.
    PubMed     Text format     Related articles    Abstract available



  81. MUTANGA TF , de Boer HC, van der Wielen GJ, Hoogeman MS, et al
    Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
    Int J Radiat Oncol Biol Phys. 2011;81:1160-7.
    PubMed     Text format     Related articles    Abstract available



  82. ZAULS AJ , Ashenafi MS, Onicescu G, Clarke HS, et al
    Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2011;81:1010-6.
    PubMed     Text format     Related articles    Abstract available



  83. QUON H , Cheung PC, Andrew Loblaw D, Morton G, et al
    Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  84. MARGALIT DN , Kasperzyk JL, Martin NE, Sesso HD, et al
    Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians' Health Study.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  85. HERBERT C , Liu M, Tyldesley S, Morris WJ, et al
    Biochemical Control with Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90%
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  86. SWISHER-MCCLURE S , Pollack CE, Christodouleas JP, Guzzo TJ, et al
    Variation in Use of Androgen Suppression with External-Beam Radiotherapy for Nonmetastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  87. VANCE SM , Stenmark MH, Blas K, Halverson S, et al
    Percentage of Cancer Volume in Biopsy Cores is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated with Dose-Escalated External Beam Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  88. OST P , De Meerleer G, Vercauteren T, De Gersem W, et al
    Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines.
    Int J Radiat Oncol Biol Phys. 2011;81:e143-9.
    PubMed     Text format     Related articles    Abstract available



  89. SU Z , Zhang L, Murphy M, Williamson J, et al
    Analysis of prostate patient setup and tracking data: potential intervention strategies.
    Int J Radiat Oncol Biol Phys. 2011;81:880-7.
    PubMed     Text format     Related articles    Abstract available



  90. MITERA G , Probyn L, Ford M, Donovan A, et al
    Correlation of computed tomography imaging features with pain response in patients with spine metastases after radiation therapy.
    Int J Radiat Oncol Biol Phys. 2011;81:827-30.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  91. FONTEYNE V , Ost P, Villeirs G, Oosterlinck W, et al
    Improving Positioning in High-Dose Radiotherapy for Prostate Cancer: Safety and Visibility of Frequently Used Gold Fiducial Markers.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  92. TURAKA A , Buyyounouski MK, Hanlon AL, Horwitz EM, et al
    Hypoxic Prostate/Muscle Po(2) Ratio Predicts for Outcome in Patients with Localized Prostate Cancer: Long-Term Results.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  93. FIORINO C , Rancati T, Fellin G, Vavassori V, et al
    Late Fecal Incontinence After High-Dose Radiotherapy for Prostate Cancer: Better Prediction Using Longitudinal Definitions.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  94. GLATSTEIN E
    The omega on alpha and beta.
    Int J Radiat Oncol Biol Phys. 2011;81:319-20.
    PubMed     Text format     Related articles   



  95. TUCKER SL , Thames HD, Michalski JM, Bosch WR, et al
    Estimation of alpha/beta for late rectal toxicity based on RTOG 94-06.
    Int J Radiat Oncol Biol Phys. 2011;81:600-5.
    PubMed     Text format     Related articles    Abstract available



  96. MOORE KL , Brame RS, Low DA, Mutic S, et al
    Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Int J Radiat Oncol Biol Phys. 2011;81:545-51.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  97. KANG J , Chen MH, Zhang Y, Moran BJ, et al
    Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  98. ISEBAERT SF , Swinnen JV, McBride WH, Begg AC, et al
    5-Aminoimidazole-4-Carboxamide Riboside Enhances Effect of Ionizing Radiation in PC3 Prostate Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  99. ISEBAERT SF , Swinnen JV, McBride WH, Haustermans KM, et al
    Insulin-Like Growth Factor-Type 1 Receptor Inhibitor NVP-AEW541 Enhances Radiosensitivity of PTEN Wild-Type but Not PTEN-Deficient Human Prostate Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2011;81:239-47.
    PubMed     Text format     Related articles    Abstract available



  100. LAWTON CA , Hunt D, Lee WR, Gomella L, et al
    Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05).
    Int J Radiat Oncol Biol Phys. 2011;81:1-7.
    PubMed     Text format     Related articles    Abstract available



  101. RONG Y , Tang G, Welsh JS, Mohiuddin MM, et al
    Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions.
    Int J Radiat Oncol Biol Phys. 2011;81:284-96.
    PubMed     Text format     Related articles    Abstract available



  102. CUI Y , Galvin JM, Straube WL, Bosch WR, et al
    Multi-system verification of registrations for image-guided radiotherapy in clinical trials.
    Int J Radiat Oncol Biol Phys. 2011;81:305-12.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  103. FENG FY , Qian Y, Stenmark MH, Halverson S, et al
    Perineural Invasion Predicts Increased Recurrence, Metastasis, and Death from Prostate Cancer following Treatment with Dose-Escalated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  104. OYMAK E , Onal C
    Response to "the impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy" (int j radiat oncol biol phys 2011;79:379-384).
    Int J Radiat Oncol Biol Phys. 2011;80:1603.
    PubMed     Text format     Related articles   



  105. SCHULZ RJ , Kagan AR
    Dose escalation in the radiation therapy of prostate cancer.
    Int J Radiat Oncol Biol Phys. 2011;80:1289-91.
    PubMed     Text format     Related articles   



  106. CHEN FH , Chiang CS, Wang CC, Fu SY, et al
    Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
    Int J Radiat Oncol Biol Phys. 2011;80:1512-21.
    PubMed     Text format     Related articles    Abstract available



  107. GRASSBERGER C , Trofimov A, Lomax A, Paganetti H, et al
    Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.
    Int J Radiat Oncol Biol Phys. 2011;80:1559-66.
    PubMed     Text format     Related articles    Abstract available



  108. CROOK J , Borg J, Evans A, Toi A, et al
    10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.
    Int J Radiat Oncol Biol Phys. 2011;80:1323-9.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  109. CURY FL , Duclos M, Aprikian A, Patrocinio H, et al
    Single-Fraction High Dose Rate Brachytherapy and Hypofractionated External Beam Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer - Long Term Results.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  110. OHRI N , Dicker AP, Showalter TN
    In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?).
    Int J Radiat Oncol Biol Phys. 2011;80:1279.
    PubMed     Text format     Related articles   



  111. ROELOFFZEN EM , Battermann JJ, van Deursen MJ, Monninkhof EM, et al
    Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2011;80:1072-9.
    PubMed     Text format     Related articles    Abstract available



  112. PAHLAJANI N , Ruth KJ, Buyyounouski MK, Chen DY, et al
    Radiotherapy Doses of 80 Gy and Higher are Associated with Lower Mortality in Men with Gleason Score 8 to 10 Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  113. NGUYEN PL , Chen MH, Beckman JA, Beard CJ, et al
    Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men with High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  114. HOSKIN P , Rojas A, Lowe G, Bryant L, et al
    High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer in Patients at Moderate or High Risk of Biochemical Recurrence.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  115. TENDULKAR RD , Reddy CA, Stephans KL, Ciezki JP, et al
    Redefining High-risk Prostate Cancer Based on Distant Metastases and Mortality After High-dose Radiotherapy with Androgen Deprivation Therapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  116. TSUMURA H , Satoh T, Ishiyama H, Tabata KI, et al
    Comparison of Prophylactic Naftopidil, Tamsulosin, and Silodosin for (125)I Brachytherapy-Induced Lower Urinary Tract Symptoms in Patients with Prostate Cancer: Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  117. LIPS IM , Kotte AN, van Gils CH, van Leerdam ME, et al
    Influence of Antiflatulent Dietary Advice on Intrafraction Motion for Prostate Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  118. TAIRA AV , Merrick GS, Galbreath RW, Butler WM, et al
    Distant Metastases Following Permanent Interstitial Brachytherapy for Patients With Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  119. DEFRAENE G , Van den Bergh L, Al-Mamgani A, Haustermans K, et al
    The Benefits of Including Clinical Factors in Rectal Normal Tissue Complication Probability Modeling After Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  120. STENMARK MH , Blas K, Halverson S, Sandler HM, et al
    Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated with Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  121. WILLIAMS SG
    A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer: in regard to diez p, et Al. (Int j radiat oncol biol phys 2010;77:1066-1071).
    Int J Radiat Oncol Biol Phys. 2011;80:639.
    PubMed     Text format     Related articles   



  122. DAI Y , Bae K, Siemann DW
    Impact of Hypoxia on the Metastatic Potential of Human Prostate Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  123. UESUGI T , Saika T, Edamura K, Nose H, et al
    Primary Gleason Grade 4 Impact on Biochemical Recurrence After Permanent Interstitial Brachytherapy in Japanese Patients with Low- or Intermediate-risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  124. VALDAGNI R , Kattan MW, Rancati T, Yu C, et al
    Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  125. MEIJER HJ , van Lin EN, Debats OA, Witjes JA, et al
    High Occurrence of Aberrant Lymph Node Spread on Magnetic Resonance Lymphography in Prostate Cancer Patients with a Biochemical Recurrence After Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  126. LOPES CO , Callera F
    Three-Dimensional Conformal Radiotherapy in Prostate Cancer Patients: Rise in Interleukin 6 (IL-6) but not IL-2, IL-4, IL-5, Tumor Necrosis Factor-alpha, MIP-1-alpha, and LIF Levels.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  127. HANNA SA , Pimenta Neves-Junior WF, Marta GN, Haddad CM, et al
    Role of Intra- or Periprostatic Calcifications in Image-Guided Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  128. FLEMING C , Kelly C, Thirion P, Fitzpatrick K, et al
    A method for the prediction of late organ-at-risk toxicity after radiotherapy of the prostate using equivalent uniform dose.
    Int J Radiat Oncol Biol Phys. 2011;80:608-13.
    PubMed     Text format     Related articles    Abstract available



  129. KEHWAR TS , Jones HA, Huq MS, Smith RP, et al
    Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.
    Int J Radiat Oncol Biol Phys. 2011;80:621-7.
    PubMed     Text format     Related articles    Abstract available



  130. HAVERKORT MA , van de Kamer JB, Pieters BR, van Tienhoven G, et al
    Position verification for the prostate: effect on rectal wall dose.
    Int J Radiat Oncol Biol Phys. 2011;80:462-8.
    PubMed     Text format     Related articles    Abstract available



  131. ADAMSON J , Wu Q, Yan D
    Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.
    Int J Radiat Oncol Biol Phys. 2011;80:453-61.
    PubMed     Text format     Related articles    Abstract available



  132. RODRIGUES G , Bae K, Roach M, Lawton C, et al
    Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials.
    Int J Radiat Oncol Biol Phys. 2011;80:445-52.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  133. COEN JJ , Paly JJ, Niemierko A, Weyman E, et al
    Long-Term Quality of Life Outcome after Proton Beam Monotherapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  134. AKINO Y , Koizumi M, Sumida I, Takahashi Y, et al
    Megavoltage Cone Beam Computed Tomography Dose and the Necessity of Reoptimization for Imaging Dose-Integrated Intensity-Modulated Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  135. OKAMOTO M , Ishikawa H, Ebara T, Kato H, et al
    Rectal Bleeding After High-Dose-Rate Brachytherapy Combined with Hypofractionated External-Beam Radiotherapy for Localized Prostate Cancer: The Relationship Between Dose-Volume Histogram Parameters and the Occurrence Rate.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  136. CREHANGE G , Maingon P, Gauthier M, Parfait S, et al
    Early Choline Levels from 3-Tesla MR Spectroscopy After Exclusive Radiation Therapy in Patients with Clinically Localized Prostate Cancer are Predictive of Plasmatic Levels of PSA at 1 Year.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  137. KRAUSS DJ , Hayek S, Amin M, Ye H, et al
    Prognostic Significance of Neuroendocrine Differentiation in Patients with Gleason Score 8-10 Prostate Cancer Treated with Primary Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  138. MIHAYLOV IB , Fatyga M, Bzdusek K, Gardner K, et al
    Biological Optimization in Volumetric Modulated Arc Radiotherapy for Prostate Carcinoma.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  139. NICHOLS RC JR , Morris CG, Hoppe BS, Henderson RH, et al
    Proton Radiotherapy for Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  140. BARKATI M , Williams SG, Foroudi F, Tai KH, et al
    High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  141. DAVIDSON MT , Blake SJ, Batchelar DL, Cheung P, et al
    Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles   



  142. VOGELIUS IR , Bentzen SM
    A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate Cancer: In Regard to Arcangeli C, et al. (Int J Radiat Oncol Biol Phys 2010;78:11-18).
    Int J Radiat Oncol Biol Phys. 2011;80:316.
    PubMed     Text format     Related articles   



  143. MORIKAWA LK , Roach M 3rd
    Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.
    Int J Radiat Oncol Biol Phys. 2011;80:6-16.
    PubMed     Text format     Related articles    Abstract available



  144. KING CR
    Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?
    Int J Radiat Oncol Biol Phys. 2011;80:1-3.
    PubMed     Text format     Related articles   



  145. SWANSON GP , Du F, Michalek JE, Hermans M, et al
    Long-term follow-up and risk of cancer death after radiation for post-prostatectomy rising prostate-specific antigen.
    Int J Radiat Oncol Biol Phys. 2011;80:62-8.
    PubMed     Text format     Related articles    Abstract available



  146. ROELOFFZEN EM , Monninkhof EM, Battermann JJ, van Roermund JG, et al
    Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate.
    Int J Radiat Oncol Biol Phys. 2011;80:76-84.
    PubMed     Text format     Related articles    Abstract available



  147. FOSTER W , Cunha JA, Hsu IC, Weinberg V, et al
    Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2011;80:85-90.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  148. TODOR DA , Barani IJ, Lin PS, Anscher MS, et al
    Moving Toward Focal Therapy in Prostate Cancer: Dual-Isotope Permanent Seed Implants as a Possible Solution.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles   



  149. MORETTI L , Niermann K, Schleicher S, Giacalone NJ, et al
    MLN8054, a Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles   



  150. BEKELMAN JE , Mitra N, Efstathiou J, Liao K, et al
    Outcomes After Intensity-Modulated Versus Conformal Radiotherapy in Older Men with Nonmetastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  151. DENG J , Chen Z, Yu JB, Roberts KB, et al
    Testicular Doses in Image-Guided Radiotherapy of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  152. SABOLCH A , Feng FY, Daignault-Newton S, Halverson S, et al
    Gleason Pattern 5 is the Greatest Risk Factor for Clinical Failure and Death from Prostate Cancer after Dose-Escalated Radiation Therapy and Hormonal Ablation.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  153. WONG WW , Schild SE, Vora SA, Ezzell GA, et al
    Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111-Capromab Pendetide (ProstaScint) Imaging.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  154. VESPRINI D , Sia M, Lockwood G, Moseley D, et al
    Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  155. TAIRA AV , Merrick GS, Galbreath RW, Butler WM, et al
    Serum Testosterone Kinetics After Brachytherapy for Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  156. LEBORGNE F , Fowler J, Leborgne JH, Mezzera J, et al
    Later Outcomes and Alpha/Beta Estimate From Hypofractionated Conformal Three-Dimensional Radiotherapy Versus Standard Fractionation for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  157. COEN JJ , Zietman AL, Rossi CJ, Grocela JA, et al
    Comparison of High-Dose Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  158. OLSEN JR , Noel CE, Baker K, Santanam L, et al
    Practical Method of Adaptive Radiotherapy for Prostate Cancer Using Real-Time Electromagnetic Tracking.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  159. HAYES M , Roach M 3rd
    Predicting the risk of pelvic node involvement in men with prostate cancer in the contemporary era: change you can believe?: in regard to yu, et Al. (Int j radiat oncol biol phys in press).
    Int J Radiat Oncol Biol Phys. 2011;79:1598.
    PubMed     Text format     Related articles   



  160. VALICENTI RK , Bae K, Michalski J, Sandler H, et al
    Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of radiation therapy oncology group 94-06.
    Int J Radiat Oncol Biol Phys. 2011;79:1323-9.
    PubMed     Text format     Related articles    Abstract available



  161. BUTTERWORTH KT , McGarry CK, Trainor C, O'Sullivan JM, et al
    Out-of-field cell survival following exposure to intensity-modulated radiation fields.
    Int J Radiat Oncol Biol Phys. 2011;79:1516-22.
    PubMed     Text format     Related articles    Abstract available



  162. GANSWINDT U , Schilling D, Muller AC, Bares R, et al
    Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas.
    Int J Radiat Oncol Biol Phys. 2011;79:1364-72.
    PubMed     Text format     Related articles    Abstract available



  163. ASHAMALLA H , Jiang ML, Guirguis A, Peluso F, et al
    Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy.
    Int J Radiat Oncol Biol Phys. 2011;79:1358-63.
    PubMed     Text format     Related articles    Abstract available



  164. KING BL , Butler WM, Merrick GS, Kurko BS, et al
    Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy.
    Int J Radiat Oncol Biol Phys. 2011;79:1350-7.
    PubMed     Text format     Related articles    Abstract available



  165. TYLDESLEY S , Delaney G, Foroudi F, Barbera L, et al
    Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia.
    Int J Radiat Oncol Biol Phys. 2011;79:1507-15.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  166. HAMSTRA DA , Bae K, Pilepich MV, Hanks GE, et al
    Older Age Predicts Decreased Metastasis and Prostate Cancer-Specific Death for Men Treated with Radiation Therapy: Meta-Analysis of Radiation Therapy Oncology Group Trials.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  167. RICKLES DJ
    Integrated Prostate Cancer Centers and Over-Utilization of IMRT: In Regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Int J Radiat Oncol Biol Phys. 2011;79:1280.
    PubMed     Text format     Related articles   



  168. CARLSON DJ , Keall PJ, Loo BW Jr, Chen ZJ, et al
    Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.
    Int J Radiat Oncol Biol Phys. 2011;79:1188-95.
    PubMed     Text format     Related articles    Abstract available



  169. SHAFFER R , Pickles T, Lee R, Moiseenko V, et al
    Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure.
    Int J Radiat Oncol Biol Phys. 2011;79:1029-36.
    PubMed     Text format     Related articles    Abstract available



  170. GRECO C , Zelefsky MJ, Lovelock M, Fuks Z, et al
    Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases.
    Int J Radiat Oncol Biol Phys. 2011;79:1151-7.
    PubMed     Text format     Related articles    Abstract available



  171. SHIRAISHI Y , Yorozu A, Ohashi T, Toya K, et al
    Dose Constraint for Minimizing Grade 2 Rectal Bleeding Following Brachytherapy Combined with External Beam Radiotherapy for Localized Prostate Cancer: Rectal Dose-Volume Histogram Analysis of 457 Patients.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  172. JERECZEK-FOSSA BA , Orecchia R, Bonora M, Scardino E, et al
    Response to "Urinary Obstruction in Prostate Cancer Patients From the Dutch Trial (68 Gy vs. 78 Gy): Relationships With Local Dose, Acute Effects, and Baseline Characteristics" (Int J Radiat Oncol Biol Phys 2010;78:19-25).
    Int J Radiat Oncol Biol Phys. 2011;79:956.
    PubMed     Text format     Related articles   



  173. OST P , Speleers B, De Meerleer G, De Neve W, et al
    Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Int J Radiat Oncol Biol Phys. 2011;79:920-6.
    PubMed     Text format     Related articles    Abstract available



  174. PERKS J , Turnbull H, Liu T, Purdy J, et al
    Vector analysis of prostate patient setup with image-guided radiation therapy via kV cone beam computed tomography.
    Int J Radiat Oncol Biol Phys. 2011;79:915-9.
    PubMed     Text format     Related articles    Abstract available



  175. WILLIAMS S , Buyyounouski M, Kestin L, Duchesne G, et al
    Predictors of androgen deprivation therapy efficacy combined with prostatic irradiation: the central role of tumor stage and radiation dose.
    Int J Radiat Oncol Biol Phys. 2011;79:724-31.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  176. QIAN Y , Feng FY, Halverson S, Blas K, et al
    The Percent of Positive Biopsy Cores Improves Prediction of Prostate Cancer-Specific Death in Patients Treated With Dose-Escalated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  177. MIRALBELL R , Roberts SA, Zubizarreta E, Hendry JH, et al
    Dose-Fractionation Sensitivity of Prostate Cancer Deduced from Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: alpha/beta = 1.4 (0.9-2.2) Gy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  178. DEMANES DJ , Martinez AA, Ghilezan M, Hill DR, et al
    High-Dose-Rate Monotherapy: Safe and Effective Brachytherapy for Patients with Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  179. RAHMAN S , Cosmatos H, Dave G, Williams S, et al
    Predicting Pelvic Lymph Node Involvement in Current-Era Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  180. KING CR , Brooks JD, Gill H, Presti JC Jr, et al
    Long-Term Outcomes from a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  181. ZHU XR , Poenisch F, Song X, Johnson JL, et al
    Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  182. MARTINEZ AA , Gonzalez J, Ye H, Ghilezan M, et al
    Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy.
    Int J Radiat Oncol Biol Phys. 2011;79:363-70.
    PubMed     Text format     Related articles    Abstract available



  183. UDAYAKUMAR TS , Stoyanova R, Hachem P, Ahmed MM, et al
    Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
    Int J Radiat Oncol Biol Phys. 2011;79:549-58.
    PubMed     Text format     Related articles    Abstract available



  184. JAIN S , Coulter JA, Hounsell AR, Butterworth KT, et al
    Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.
    Int J Radiat Oncol Biol Phys. 2011;79:531-9.
    PubMed     Text format     Related articles    Abstract available



  185. SUCHOWERSKA N , Jackson M, Lambert J, Yin YB, et al
    Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors.
    Int J Radiat Oncol Biol Phys. 2011;79:609-15.
    PubMed     Text format     Related articles    Abstract available



  186. ENGELSMAN M , DeLaney TF, Hong TS
    Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions.
    Int J Radiat Oncol Biol Phys. 2011;79:616-22.
    PubMed     Text format     Related articles    Abstract available



  187. DIOT Q , Olsen C, Kavanagh B, Raben D, et al
    Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients.
    Int J Radiat Oncol Biol Phys. 2011;79:623-32.
    PubMed     Text format     Related articles    Abstract available



  188. KIRILOVA A , Damyanovich A, Crook J, Jezioranski J, et al
    3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    Int J Radiat Oncol Biol Phys. 2011;79:371-8.
    PubMed     Text format     Related articles    Abstract available



  189. LAMB DS , Denham JW, Joseph D, Matthews J, et al
    A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial.
    Int J Radiat Oncol Biol Phys. 2011;79:385-91.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  190. JERECZEK-FOSSA BA , Beltramo G, Fariselli L, Fodor C, et al
    Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  191. MANTINI G , Tagliaferri L, Mattiucci GC, Balducci M, et al
    Effect of Whole Pelvic Radiotherapy for Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Long-Term Androgen Deprivation Therapy.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  192. KONSOULA Z , Cao H, Velena A, Jung M, et al
    Adamantanyl-Histone Deacetylase Inhibitor H6CAHA Exhibits Favorable Pharmacokinetics and Augments Prostate Cancer Radiation Sensitivity.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  193. QUON H , Cheung PC, Loblaw DA, Morton G, et al
    Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer: Late Toxicity.
    Int J Radiat Oncol Biol Phys. 2011.
    PubMed     Text format     Related articles    Abstract available



  194. KNOPF AC , Parodi K, Paganetti H, Bortfeld T, et al
    Accuracy of proton beam range verification using post-treatment positron emission tomography/computed tomography as function of treatment site.
    Int J Radiat Oncol Biol Phys. 2011;79:297-304.
    PubMed     Text format     Related articles    Abstract available



  195. KEALL PJ , Sawant A, Cho B, Ruan D, et al
    Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy.
    Int J Radiat Oncol Biol Phys. 2011;79:312-20.
    PubMed     Text format     Related articles    Abstract available



  196. ZWAHLEN DR , Smith R, Andrianopoulos N, Matheson B, et al
    Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.
    Int J Radiat Oncol Biol Phys. 2011;79:179-87.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  197. JABBARI S , Weinberg VK, Kaprealian T, Hsu IC, et al
    Stereotactic Body Radiotherapy as Monotherapy or Post-External Beam Radiotherapy Boost for Prostate Cancer: Technique, Early Toxicity, and PSA Response.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  198. MOHAMMED N , Kestin L, Ghilezan M, Krauss D, et al
    Comparison of Acute and Late Toxicities for Three Modern High-Dose Radiation Treatment Techniques for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  199. WIDESOTT L , Pierelli A, Fiorino C, Lomax AJ, et al
    Helical Tomotherapy vs. Intensity-Modulated Proton Therapy for Whole Pelvis Irradiation in High-Risk Prostate Cancer Patients: Dosimetric, Normal Tissue Complication Probability, and Generalized Equivalent Uniform Dose Analysis.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  200. ADKISON JB , McHaffie DR, Bentzen SM, Patel RR, et al
    Phase I Trial of Pelvic Nodal Dose Escalation with Hypofractionated IMRT for High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  201. PEDERSON AW , Fricano J, Correa D, Pelizzari CA, et al
    Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose-Volume Histogram Parameters to Limit Genitourinary and Gastrointestinal Toxicity.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  202. KAPREALIAN T , Weinberg V, Speight JL, Gottschalk AR, et al
    High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  203. BECKENDORF V , Guerif S, Le Prise E, Cosset JM, et al
    70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  204. ZIMBERG SH , Olsson CA
    Response to "Integrated Prostate Cancer Centers and Overutilization of IMRT: A Close Look at Fee-for-Service Medicine in Radiation Oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
    Int J Radiat Oncol Biol Phys. 2010;78:1607.
    PubMed     Text format     Related articles   



  205. ADAMSON J , Wu Q
    Prostate intrafraction motion assessed by simultaneous kV fluoroscopy at MV delivery II: adaptive strategies.
    Int J Radiat Oncol Biol Phys. 2010;78:1323-30.
    PubMed     Text format     Related articles    Abstract available



  206. ADAMSON J , Wu Q
    Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis.
    Int J Radiat Oncol Biol Phys. 2010;78:1563-70.
    PubMed     Text format     Related articles    Abstract available



  207. TANYI JA , He T, Summers PA, Mburu RG, et al
    Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
    Int J Radiat Oncol Biol Phys. 2010;78:1579-85.
    PubMed     Text format     Related articles    Abstract available



  208. LUGHEZZANI G , Sun M, Perrotte P, Alasker A, et al
    Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
    Int J Radiat Oncol Biol Phys. 2010;78:1307-13.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  209. COZZARINI C , Fiorino C, Da Pozzo LF, Alongi F, et al
    Clinical Factors Predicting Late Severe Urinary Toxicity After Postoperative Radiotherapy for Prostate Carcinoma: A Single-Institute Analysis of 742 Patients.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  210. ROSENTHAL SA , Bittner NH, Beyer DC, Demanes DJ, et al
    American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Transperineal Permanent Brachytherapy of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  211. MENDENHALL NP , Li Z, Hoppe BS, Marcus RB Jr, et al
    Early Outcomes from Three Prospective Trials of Image-guided Proton Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  212. KONG Z , Raghavan P, Xie D, Boike T, et al
    Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Int J Radiat Oncol Biol Phys. 2010;78:1210-8.
    PubMed     Text format     Related articles    Abstract available



  213. BITTNER N , Merrick GS, Galbreath RW, Butler WM, et al
    Greater biopsy core number is associated with improved biochemical control in patients treated with permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2010;78:1104-10.
    PubMed     Text format     Related articles    Abstract available



  214. LIIKANEN I , Dias JD, Nokisalmi P, Sloniecka M, et al
    Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo.
    Int J Radiat Oncol Biol Phys. 2010;78:1201-9.
    PubMed     Text format     Related articles    Abstract available



  215. SHCHORY T , Schifter D, Lichtman R, Neustadter D, et al
    Tracking accuracy of a real-time fiducial tracking system for patient positioning and monitoring in radiation therapy.
    Int J Radiat Oncol Biol Phys. 2010;78:1227-34.
    PubMed     Text format     Related articles    Abstract available



  216. TUCKER SL , Dong L, Bosch WR, Michalski J, et al
    Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
    Int J Radiat Oncol Biol Phys. 2010;78:1253-60.
    PubMed     Text format     Related articles    Abstract available



  217. MORRIER J , Chretien M, Martin AG, Vigneault E, et al
    A more efficient, radiation-free alternative to systematic chest x-ray for the detection of embolized seeds to the lung.
    Int J Radiat Oncol Biol Phys. 2010;78:1052-6.
    PubMed     Text format     Related articles    Abstract available



  218. MEIJER HJ , Debats OA, Kunze-Busch M, van Kollenburg P, et al
    Magnetic Resonance Lymphography-Guided Selective High-Dose Lymph Node IRRADIATION in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  219. SHARMA NK , Li T, Chen DY, Pollack A, et al
    Intensity-Modulated Radiotherapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  220. JIN H , Palta JR, Kim YH, Kim S, et al
    Application of a novel dose-uncertainty model for dose-uncertainty analysis in prostate intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys. 2010;78:920-8.
    PubMed     Text format     Related articles    Abstract available



  221. LIU W , Luxton G, Xing L
    A failure detection strategy for intrafraction prostate motion monitoring with on-board imagers for fixed-gantry IMRT.
    Int J Radiat Oncol Biol Phys. 2010;78:904-11.
    PubMed     Text format     Related articles    Abstract available



  222. WEISS E , Wu J, Sleeman W, Bryant J, et al
    Clinical evaluation of soft tissue organ boundary visualization on cone-beam computed tomographic imaging.
    Int J Radiat Oncol Biol Phys. 2010;78:929-36.
    PubMed     Text format     Related articles    Abstract available



  223. HSU IC , Bae K, Shinohara K, Pouliot J, et al
    Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.
    Int J Radiat Oncol Biol Phys. 2010;78:751-8.
    PubMed     Text format     Related articles    Abstract available



  224. MASUCCI GL , Donath D, Tetreault-Laflamme A, Carrier JF, et al
    Comparison between high and low source activity seeds for I-125 permanent seed prostate brachytherapy.
    Int J Radiat Oncol Biol Phys. 2010;78:781-6.
    PubMed     Text format     Related articles    Abstract available



  225. KUBICEK GJ , Naguib M, Redfield S, Grayback N, et al
    PSA decrease during combined-modality radiotherapy predicts for treatment outcome.
    Int J Radiat Oncol Biol Phys. 2010;78:759-62.
    PubMed     Text format     Related articles    Abstract available



  226. YEOH EK , Bartholomeusz DL, Holloway RH, Fraser RJ, et al
    Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate.
    Int J Radiat Oncol Biol Phys. 2010;78:773-80.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  227. HUSSAIN A , Wu Y, Mirmiran A, Dibiase S, et al
    Long-Term Follow-up of a Prospective Trial of Trimodality Therapy of Weekly Paclitaxel, Radiation, and Androgen Deprivation in High-risk Prostate Cancer With or Without Prior Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  228. DIBIASE SJ , Hussain A, Kataria R, Amin P, et al
    Long-Term Results of a Prospective, Phase II Study of Long-term Androgen Ablation, Pelvic Radiotherapy, Brachytherapy Boost, and Adjuvant Docetaxel in Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  229. GEINITZ H , Thamm R, Keller M, Astner ST, et al
    Longitudinal Study of Intestinal Symptoms and Fecal Continence in Patients with Conformal Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  230. ELLIS RJ , Kaminsky DA, Zhou EH, Fu P, et al
    Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed with Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  231. OGAWA K , Nakamura K, Sasaki T, Onishi H, et al
    Radical External Beam Radiotherapy for Clinically Localized Prostate Cancer in Japan: Changing Trends in the Patterns of Care Process Survey.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  232. TROFIMOV A , Nguyen PL, Efstathiou JA, Wang Y, et al
    Interfractional Variations in the Setup of Pelvic Bony Anatomy and Soft Tissue, and Their Implications on the Delivery of Proton Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  233. YEOH EE , Botten RJ, Butters J, Di Matteo AC, et al
    Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Carcinoma: Final Results of Phase III Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  234. PESCHKE P , Karger CP, Scholz M, Debus J, et al
    Relative Biological Effectiveness of Carbon Ions for Local Tumor Control of a Radioresistant Prostate Carcinoma in the Rat.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  235. WAHLGREN T , Levitt S, Kowalski J, Nilsson S, et al
    Use of the Charlson Combined Comorbidity Index To Predict Postradiotherapy Quality of Life for Prostate Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  236. COEN JJ , Bae K, Zietman AL, Patel B, et al
    Acute and Late Toxicity After Dose Escalation to 82 GyE Using Conformal Proton Radiation for Localized Prostate Cancer: Initial Report of American College of Radiology Phase II Study 03-12.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  237. FANG LC , Merrick GS, Butler WM, Galbreath RW, et al
    High-Risk Prostate Cancer With Gleason Score 8-10 and PSA Level </=15 ng/ mL Treated With Permanent Interstitial Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  238. HOUSRI N , Ning H, Ondos J, Choyke P, et al
    Parameters Favorable to Intraprostatic Radiation Dose Escalation in Men with Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  239. LIAUW SL , Liauw SH
    Prolongation of Total Treatment Time Because of Infrequently Missed Days of Treatment is Not Associated With Inferior Biochemical Outcome After Dose-Escalated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  240. ZAPATERO A , Garcia-Vicente F, Martin de Vidales C, Cruz Conde A, et al
    Long-Term Results After High-Dose Radiotherapy and Adjuvant Hormones in Prostate Cancer: How Curable Is High-Risk Disease?
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  241. KERNS SL , Ostrer H, Stock R, Li W, et al
    Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  242. FOWLER JF , Dale RG
    When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304).
    Int J Radiat Oncol Biol Phys. 2010;78:640-1.
    PubMed     Text format     Related articles   



  243. GOMEZ-ITURRIAGA PINA A , Crook J, Borg J, Ma C, et al
    Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) >/=180 Gy.
    Int J Radiat Oncol Biol Phys. 2010;78:422-7.
    PubMed     Text format     Related articles    Abstract available



  244. LIU W , Wiersma RD, Xing L
    Optimized hybrid megavoltage-kilovoltage imaging protocol for volumetric prostate arc therapy.
    Int J Radiat Oncol Biol Phys. 2010;78:595-604.
    PubMed     Text format     Related articles    Abstract available



  245. THOMPSON A , Keyes M, Pickles T, Palma D, et al
    Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?
    Int J Radiat Oncol Biol Phys. 2010;78:415-21.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  246. SMITSMANS MH , de Bois J, Sonke JJ, Catton CN, et al
    Residual Seminal Vesicle Displacement in Marker-Based Image-Guided Radiotherapy for Prostate Cancer and the Impact on Margin Design.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  247. ZILLI T , Jorcano S, Rouzaud M, Dipasquale G, et al
    Twice-Weekly Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer with Low-Risk Nodal Involvement: Toxicity and Outcome from a Dose Escalation Pilot Study.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  248. BARNEY BM , Lee RJ, Handrahan D, Welsh KT, et al
    Image-Guided Radiotherapy (IGRT) for Prostate Cancer Comparing kV Imaging of Fiducial Markers With Cone Beam Computed Tomography (CBCT).
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  249. GEINITZ H , Thamm R, Mueller T, Jess K, et al
    Impact of Body Mass Index on Outcomes After Conformal Radiotherapy in Patients with Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



  250. SYLVESTER JE , Grimm PD, Wong J, Galbreath RW, et al
    Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival following I(125) Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: